Wall Street Analysts Predict a 26.18% Upside in Mirum Pharmaceuticals (MIRM): Here's What You Should Know
Portfolio Pulse from
Analysts predict a 26.18% upside for Mirum Pharmaceuticals (MIRM) based on price targets. Despite the metric's mixed reliability, consensus on raised earnings estimates suggests potential stock growth.
February 26, 2025 | 4:15 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Analysts predict a 26.18% upside for Mirum Pharmaceuticals (MIRM) based on price targets. Despite the metric's mixed reliability, consensus on raised earnings estimates suggests potential stock growth.
The article highlights a significant 26.18% upside potential for MIRM based on analysts' price targets. While price targets alone may not always be reliable, the strong consensus among analysts in raising earnings estimates provides a solid basis for expecting stock growth.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100